GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conformis Inc (STU:3080) » Definitions » Selling and Marketing Expense

Conformis (STU:3080) Selling and Marketing Expense : €20.24 Mil (TTM As of Jun. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Conformis Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Conformis's Selling and Marketing Expense for the three months ended in Jun. 2023 was €3.75 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023 was €20.24 Mil.


Conformis Selling and Marketing Expense Historical Data

The historical data trend for Conformis's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conformis Selling and Marketing Expense Chart

Conformis Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.24 25.66 18.62 22.04 23.89

Conformis Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.21 5.62 6.15 4.72 3.75

Conformis Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €20.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Conformis Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Conformis's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Conformis (STU:3080) Business Description

Traded in Other Exchanges
N/A
Address
600 Technology Park Drive, Billerica, MA, USA, 01821
Conformis Inc is a United States-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.

Conformis (STU:3080) Headlines

No Headlines